Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Hair glycation could be a reliable non-invasive indicator of blood glucose control, but its use is limited by factors like sample collection and hair treatments.

TRH stimulates human hair growth and extends the hair growth phase.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Oral lichen planus is not linked to sex hormone levels.

Recombinant human growth hormone helps burn wounds heal faster by increasing blood vessel growth.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Laser hair removal doesn't affect thyroid hormones.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.